Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
Status:
Unknown status
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
To compare clinical outcomes in patients with chronic kidney disease (CKD) presenting with an
acute coronary syndrome (ACS) treated with clopidogrel or ticagrelor (both FDA approved and
guideline indicated drugs for treating these patients upstream managed medically or with
coronary revascularization).